Dr. Mark Currie
Ironwood Pharmaceuticals has appointed Dr. Mark Currie to senior vice president, chief scientific officer (CSO), and president of research and development (R&D).
Dr. Currie has been at Ironwood since 2002, leading the company’s R&D efforts.
Ironwood CEO Peter Hecht said that “Mark’s outstanding contributions to Ironwood are invaluable as we move our R&D efforts forward, growing our active pipeline and expanding our development efforts globally on behalf of our shareholders and the patients we aim to serve.”